Home › Targets › CLDN18.2

CLDN18.2 (2 companies · 6 programs)

Companies with an active program directed at CLDN18.2.

NovaBridge Biosciences NBP

givastomig — Gastric Cancer Phase 1
givastomig — Biliary Tract Cancer Phase 1
givastomig — Pancreatic Cancer Phase 1

Xencor Inc XNCR

ASP2138 — Gastric Cancer Phase 1
ASP2138 — Gastroesophageal Junction Cancer Phase 1
ASP2138 — Pancreatic Cancer Phase 1